Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bidlingmaier

Showing results (41-50 of 307) with videos related to

Pageof 31
Sort By:
European Journal of Endocrinology|May 28, 2021
MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal modelsArne Hinrichs, Simone Renner, Martin Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axisRobert D Murray, Martin Bidlingmaier, Christian J Strasburger, et al.
Clinical Diabetes and Endocrinology|September 6, 2018
Growth hormone: isoforms, clinical aspects and assays interferenceJúnia Ribeiro de Oliveira Longo Schweizer, Antônio Ribeiro-Oliveira, Martin Bidlingmaier
The Journal of Clinical Endocrinology and Metabolism|May 7, 2010
A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humansJohannes D Veldhuis, Martin Bidlingmaier, Joy Bailey, et al.
Neuroendocrinology|November 12, 2019
Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyMatthias K Auer, Aniko Krumbholz, Martin Bidlingmaier, et al.
European Journal of Endocrinology|December 10, 2016
Anthropometric factors have significant influence on the outcome of the GHRH-arginine test: establishment of normative data for an automated immunoassay specifically measuring 22 kDa human growth hormoneTimo Deutschbein, Martin Bidlingmaier, Jochen Schopohl, et al.
Hypertension (Dallas, Tex. : 1979)|June 10, 2015
Genetic and potential autoimmune triggers of primary aldosteronismTracy Ann Williams, Paolo Mulatero, Martin Bidlingmaier, et al.
Analytical Biochemistry|March 16, 2010
Quantification of growth hormone in serum by isotope dilution mass spectrometryCristian G Arsene, André Henrion, Nina Diekmann, et al.
Clinical Endocrinology|October 1, 2011
Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's RegistryEvelyn Fischer, Felix Beuschlein, Christoph Degenhart, et al.
Psychoneuroendocrinology|April 19, 2016
Sex-related differences in the association of salivary cortisol levels and type 2 diabetes. Findings from the cross-sectional population based KORA-age studyHamimatunnisa Johar, Rebecca Thwing Emeny, Martin Bidlingmaier, et al.
Pageof 31

Showing results (41-50 of 307) with videos related to

Sort By:
Pageof 31
European Journal of Endocrinology|May 28, 2021
MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal modelsArne Hinrichs, Simone Renner, Martin Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axisRobert D Murray, Martin Bidlingmaier, Christian J Strasburger, et al.
Clinical Diabetes and Endocrinology|September 6, 2018
Growth hormone: isoforms, clinical aspects and assays interferenceJúnia Ribeiro de Oliveira Longo Schweizer, Antônio Ribeiro-Oliveira, Martin Bidlingmaier
The Journal of Clinical Endocrinology and Metabolism|May 7, 2010
A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humansJohannes D Veldhuis, Martin Bidlingmaier, Joy Bailey, et al.
Neuroendocrinology|November 12, 2019
Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyMatthias K Auer, Aniko Krumbholz, Martin Bidlingmaier, et al.
European Journal of Endocrinology|December 10, 2016
Anthropometric factors have significant influence on the outcome of the GHRH-arginine test: establishment of normative data for an automated immunoassay specifically measuring 22 kDa human growth hormoneTimo Deutschbein, Martin Bidlingmaier, Jochen Schopohl, et al.
Hypertension (Dallas, Tex. : 1979)|June 10, 2015
Genetic and potential autoimmune triggers of primary aldosteronismTracy Ann Williams, Paolo Mulatero, Martin Bidlingmaier, et al.
Analytical Biochemistry|March 16, 2010
Quantification of growth hormone in serum by isotope dilution mass spectrometryCristian G Arsene, André Henrion, Nina Diekmann, et al.
Clinical Endocrinology|October 1, 2011
Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's RegistryEvelyn Fischer, Felix Beuschlein, Christoph Degenhart, et al.
Psychoneuroendocrinology|April 19, 2016
Sex-related differences in the association of salivary cortisol levels and type 2 diabetes. Findings from the cross-sectional population based KORA-age studyHamimatunnisa Johar, Rebecca Thwing Emeny, Martin Bidlingmaier, et al.
Pageof 31